Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiotherapy Planning, Computer-Assisted | 115 | 2023 | 1624 | 16.030 |
Why?
|
Monte Carlo Method | 121 | 2023 | 1254 | 13.630 |
Why?
|
Relative Biological Effectiveness | 60 | 2022 | 323 | 11.120 |
Why?
|
Radiotherapy, Intensity-Modulated | 39 | 2023 | 806 | 9.130 |
Why?
|
Protons | 55 | 2023 | 1127 | 7.540 |
Why?
|
Radiometry | 50 | 2023 | 800 | 7.100 |
Why?
|
Radiotherapy Dosage | 110 | 2023 | 2879 | 7.060 |
Why?
|
Organs at Risk | 29 | 2023 | 346 | 6.960 |
Why?
|
Linear Energy Transfer | 37 | 2021 | 154 | 6.900 |
Why?
|
Photons | 27 | 2021 | 588 | 4.260 |
Why?
|
Neoplasms, Radiation-Induced | 14 | 2015 | 547 | 3.500 |
Why?
|
Neutrons | 11 | 2014 | 76 | 3.440 |
Why?
|
Neoplasms, Second Primary | 13 | 2020 | 1062 | 2.970 |
Why?
|
Phantoms, Imaging | 42 | 2023 | 2480 | 2.950 |
Why?
|
Scattering, Radiation | 25 | 2020 | 498 | 2.920 |
Why?
|
Uncertainty | 23 | 2023 | 735 | 2.870 |
Why?
|
Radiation Dosage | 30 | 2023 | 1928 | 2.790 |
Why?
|
Radiotherapy, Conformal | 12 | 2021 | 548 | 2.690 |
Why?
|
Models, Biological | 31 | 2020 | 9584 | 2.130 |
Why?
|
Radiotherapy | 17 | 2019 | 1533 | 2.060 |
Why?
|
Radiobiology | 8 | 2020 | 85 | 2.000 |
Why?
|
Radiation Oncology | 10 | 2021 | 555 | 1.950 |
Why?
|
Models, Theoretical | 20 | 2021 | 3589 | 1.940 |
Why?
|
Movement | 12 | 2019 | 1471 | 1.910 |
Why?
|
Neoplasms | 40 | 2023 | 21696 | 1.870 |
Why?
|
Radiotherapy, High-Energy | 9 | 2015 | 228 | 1.800 |
Why?
|
Head and Neck Neoplasms | 18 | 2023 | 2736 | 1.760 |
Why?
|
Algorithms | 42 | 2023 | 13882 | 1.720 |
Why?
|
Lung Neoplasms | 27 | 2023 | 13104 | 1.650 |
Why?
|
Radiotherapy, Computer-Assisted | 7 | 2015 | 94 | 1.610 |
Why?
|
Dose-Response Relationship, Radiation | 21 | 2018 | 876 | 1.600 |
Why?
|
Radiation Injuries | 13 | 2019 | 1180 | 1.590 |
Why?
|
Ependymoma | 5 | 2018 | 334 | 1.580 |
Why?
|
Lymphopenia | 4 | 2023 | 285 | 1.330 |
Why?
|
Positron-Emission Tomography | 21 | 2017 | 6234 | 1.290 |
Why?
|
Respiration | 9 | 2015 | 1653 | 1.100 |
Why?
|
Liver Neoplasms | 11 | 2023 | 4253 | 1.050 |
Why?
|
Metal Nanoparticles | 6 | 2021 | 405 | 1.040 |
Why?
|
Prostatic Neoplasms | 18 | 2022 | 11126 | 1.010 |
Why?
|
Radiation Monitoring | 3 | 2015 | 98 | 1.000 |
Why?
|
Computer Simulation | 29 | 2023 | 6194 | 0.980 |
Why?
|
DNA Damage | 12 | 2023 | 2432 | 0.930 |
Why?
|
Four-Dimensional Computed Tomography | 4 | 2020 | 145 | 0.910 |
Why?
|
Software | 13 | 2023 | 4441 | 0.890 |
Why?
|
Electrons | 8 | 2018 | 268 | 0.880 |
Why?
|
Tomography, X-Ray Computed | 27 | 2023 | 20130 | 0.870 |
Why?
|
Humans | 209 | 2023 | 744366 | 0.860 |
Why?
|
Radiation Pneumonitis | 2 | 2020 | 104 | 0.840 |
Why?
|
Infratentorial Neoplasms | 3 | 2018 | 94 | 0.840 |
Why?
|
Microtechnology | 2 | 2019 | 70 | 0.820 |
Why?
|
DNA Repair | 10 | 2023 | 2046 | 0.810 |
Why?
|
Lung | 13 | 2021 | 9857 | 0.800 |
Why?
|
Brain Stem | 5 | 2018 | 846 | 0.790 |
Why?
|
Radiation Tolerance | 8 | 2018 | 486 | 0.790 |
Why?
|
Elementary Particles | 3 | 2010 | 55 | 0.770 |
Why?
|
Brain Neoplasms | 13 | 2020 | 8861 | 0.770 |
Why?
|
Nanofibers | 1 | 2021 | 66 | 0.760 |
Why?
|
Water | 12 | 2021 | 1395 | 0.740 |
Why?
|
Models, Statistical | 17 | 2019 | 5101 | 0.740 |
Why?
|
Cell Survival | 15 | 2019 | 5882 | 0.730 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2023 | 5223 | 0.660 |
Why?
|
Radiation Protection | 6 | 2016 | 419 | 0.650 |
Why?
|
Motion | 5 | 2015 | 798 | 0.650 |
Why?
|
Rib Fractures | 1 | 2020 | 131 | 0.650 |
Why?
|
Radiosurgery | 5 | 2019 | 1329 | 0.640 |
Why?
|
Artifacts | 5 | 2019 | 1904 | 0.620 |
Why?
|
Necrosis | 3 | 2020 | 1643 | 0.610 |
Why?
|
Arteriovenous Malformations | 2 | 2019 | 396 | 0.580 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2023 | 2214 | 0.580 |
Why?
|
Metals | 3 | 2019 | 719 | 0.570 |
Why?
|
Skull Base Neoplasms | 2 | 2017 | 284 | 0.550 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2020 | 450 | 0.530 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.510 |
Why?
|
Gamma Rays | 3 | 2017 | 320 | 0.490 |
Why?
|
Lymphocytes | 5 | 2023 | 2617 | 0.490 |
Why?
|
Reproducibility of Results | 23 | 2022 | 19905 | 0.480 |
Why?
|
Gold | 5 | 2021 | 484 | 0.470 |
Why?
|
Equipment Failure Analysis | 3 | 2010 | 868 | 0.470 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 530 | 0.470 |
Why?
|
Prostate | 2 | 2022 | 1775 | 0.450 |
Why?
|
Calibration | 5 | 2018 | 816 | 0.440 |
Why?
|
Medulloblastoma | 6 | 2017 | 683 | 0.440 |
Why?
|
Physics | 3 | 2021 | 87 | 0.440 |
Why?
|
Prostheses and Implants | 4 | 2019 | 1387 | 0.430 |
Why?
|
Cerebellar Neoplasms | 5 | 2017 | 587 | 0.430 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1070 | 0.420 |
Why?
|
Chordoma | 5 | 2016 | 359 | 0.420 |
Why?
|
Models, Chemical | 2 | 2016 | 626 | 0.410 |
Why?
|
Spine | 4 | 2017 | 1144 | 0.400 |
Why?
|
Radiation, Ionizing | 4 | 2022 | 258 | 0.390 |
Why?
|
Seminoma | 1 | 2012 | 139 | 0.380 |
Why?
|
DNA Breaks, Double-Stranded | 6 | 2023 | 594 | 0.380 |
Why?
|
Radiation-Sensitizing Agents | 4 | 2016 | 358 | 0.360 |
Why?
|
Carbon | 4 | 2022 | 687 | 0.360 |
Why?
|
Tumor Burden | 5 | 2018 | 1915 | 0.360 |
Why?
|
Breast Neoplasms | 5 | 2020 | 20824 | 0.360 |
Why?
|
Nanoparticles | 1 | 2021 | 1905 | 0.340 |
Why?
|
Heart | 2 | 2021 | 4464 | 0.330 |
Why?
|
Probability | 5 | 2023 | 2506 | 0.330 |
Why?
|
DNA | 5 | 2022 | 7294 | 0.330 |
Why?
|
Sensitivity and Specificity | 14 | 2017 | 14723 | 0.330 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2007 | 1184 | 0.330 |
Why?
|
Rectum | 4 | 2017 | 904 | 0.320 |
Why?
|
Radioisotopes | 2 | 2023 | 500 | 0.320 |
Why?
|
Whole-Body Counting | 1 | 2008 | 35 | 0.320 |
Why?
|
Fetus | 1 | 2015 | 1880 | 0.320 |
Why?
|
Statistics as Topic | 1 | 2014 | 2373 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8949 | 0.310 |
Why?
|
Alpha Particles | 2 | 2021 | 26 | 0.300 |
Why?
|
Male | 47 | 2022 | 350115 | 0.300 |
Why?
|
Cyclotrons | 2 | 2004 | 30 | 0.300 |
Why?
|
Risk Assessment | 10 | 2017 | 23336 | 0.290 |
Why?
|
Equipment Design | 5 | 2010 | 3582 | 0.280 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1438 | 0.280 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2725 | 0.280 |
Why?
|
Eye Neoplasms | 4 | 2012 | 312 | 0.270 |
Why?
|
Cricetinae | 6 | 2015 | 2475 | 0.260 |
Why?
|
Testicular Neoplasms | 1 | 2012 | 806 | 0.260 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 686 | 0.260 |
Why?
|
Cell Line | 9 | 2015 | 16000 | 0.240 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2008 | 841 | 0.230 |
Why?
|
Retrospective Studies | 13 | 2023 | 77460 | 0.230 |
Why?
|
Polyethylene | 2 | 2011 | 184 | 0.230 |
Why?
|
Brain | 8 | 2023 | 26388 | 0.230 |
Why?
|
Quality Assurance, Health Care | 3 | 2014 | 2212 | 0.230 |
Why?
|
Feasibility Studies | 9 | 2017 | 5077 | 0.220 |
Why?
|
Particle Accelerators | 3 | 2009 | 173 | 0.220 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 16690 | 0.210 |
Why?
|
Health Care Costs | 1 | 2015 | 3208 | 0.210 |
Why?
|
Time Factors | 16 | 2020 | 40075 | 0.210 |
Why?
|
Hemodynamics | 2 | 2023 | 4196 | 0.200 |
Why?
|
Fibrosarcoma | 1 | 2003 | 348 | 0.200 |
Why?
|
Yttrium Radioisotopes | 1 | 2021 | 93 | 0.190 |
Why?
|
Radiography | 5 | 2015 | 7023 | 0.190 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2018 | 288 | 0.190 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2020 | 36 | 0.180 |
Why?
|
Child, Preschool | 11 | 2017 | 41005 | 0.180 |
Why?
|
Organ Specificity | 3 | 2014 | 2008 | 0.180 |
Why?
|
DNA, Neoplasm | 1 | 2005 | 1758 | 0.180 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 2019 | 286 | 0.180 |
Why?
|
Endpoint Determination | 2 | 2020 | 601 | 0.180 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 449 | 0.170 |
Why?
|
Copper | 2 | 2011 | 366 | 0.170 |
Why?
|
Cricetulus | 3 | 2015 | 818 | 0.170 |
Why?
|
Linear Models | 3 | 2016 | 5953 | 0.170 |
Why?
|
Pulse Radiolysis | 1 | 2018 | 6 | 0.170 |
Why?
|
Female | 29 | 2022 | 380193 | 0.160 |
Why?
|
Plastics | 2 | 2017 | 123 | 0.160 |
Why?
|
Biology | 1 | 2021 | 295 | 0.160 |
Why?
|
Cell Growth Processes | 1 | 2019 | 399 | 0.160 |
Why?
|
Child | 15 | 2018 | 77709 | 0.160 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.160 |
Why?
|
Animals | 21 | 2019 | 168768 | 0.150 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13693 | 0.150 |
Why?
|
Cell Physiological Phenomena | 1 | 2018 | 154 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2021 | 3508 | 0.150 |
Why?
|
Knowledge Bases | 1 | 2017 | 85 | 0.140 |
Why?
|
Adolescent | 14 | 2019 | 85779 | 0.140 |
Why?
|
Spinal Neoplasms | 3 | 2014 | 760 | 0.140 |
Why?
|
Optic Chiasm | 1 | 2016 | 87 | 0.140 |
Why?
|
Germanium | 1 | 2016 | 7 | 0.140 |
Why?
|
Pancreatic Neoplasms | 2 | 2013 | 5263 | 0.140 |
Why?
|
Drug Carriers | 1 | 2021 | 693 | 0.140 |
Why?
|
Paclitaxel | 2 | 2021 | 1708 | 0.140 |
Why?
|
Thoracic Wall | 1 | 2018 | 203 | 0.140 |
Why?
|
Infant | 7 | 2017 | 35134 | 0.140 |
Why?
|
Recombinases | 1 | 2016 | 67 | 0.140 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1454 | 0.130 |
Why?
|
Age Factors | 6 | 2017 | 18373 | 0.130 |
Why?
|
Research Report | 1 | 2019 | 355 | 0.130 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7914 | 0.130 |
Why?
|
Oxygen Radioisotopes | 1 | 2015 | 76 | 0.130 |
Why?
|
Normal Distribution | 1 | 2015 | 280 | 0.130 |
Why?
|
Computer Graphics | 2 | 2019 | 361 | 0.130 |
Why?
|
Reference Values | 3 | 2015 | 4982 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5172 | 0.130 |
Why?
|
Patient Positioning | 2 | 2014 | 324 | 0.120 |
Why?
|
Tumor Cells, Cultured | 4 | 2005 | 6313 | 0.120 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2015 | 148 | 0.120 |
Why?
|
Cobalt Radioisotopes | 3 | 2016 | 76 | 0.120 |
Why?
|
Adult | 15 | 2021 | 214052 | 0.120 |
Why?
|
Body Height | 2 | 2012 | 1578 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2015 | 254 | 0.120 |
Why?
|
Ions | 3 | 2022 | 265 | 0.120 |
Why?
|
Thoracic Neoplasms | 1 | 2015 | 268 | 0.110 |
Why?
|
CHO Cells | 3 | 2013 | 1409 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2023 | 2645 | 0.110 |
Why?
|
Cytosol | 1 | 2016 | 901 | 0.110 |
Why?
|
Optic Nerve | 1 | 2016 | 554 | 0.110 |
Why?
|
Endonucleases | 1 | 2016 | 380 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2015 | 401 | 0.110 |
Why?
|
Optic Nerve Glioma | 1 | 2012 | 32 | 0.110 |
Why?
|
Pelvis | 1 | 2017 | 730 | 0.110 |
Why?
|
Fiducial Markers | 1 | 2013 | 136 | 0.110 |
Why?
|
Urinary Bladder | 2 | 2016 | 1173 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6364 | 0.100 |
Why?
|
Physical Phenomena | 2 | 2018 | 46 | 0.100 |
Why?
|
Breast | 1 | 2020 | 1970 | 0.100 |
Why?
|
Subtraction Technique | 3 | 2009 | 525 | 0.100 |
Why?
|
Cell Nucleus | 2 | 2020 | 2969 | 0.100 |
Why?
|
Cohort Studies | 5 | 2018 | 40559 | 0.100 |
Why?
|
Occupational Exposure | 2 | 2014 | 1793 | 0.090 |
Why?
|
Meningioma | 2 | 2016 | 1209 | 0.090 |
Why?
|
Gadolinium | 1 | 2016 | 952 | 0.090 |
Why?
|
Alopecia | 1 | 2014 | 382 | 0.090 |
Why?
|
Calorimetry | 1 | 2010 | 126 | 0.090 |
Why?
|
Meningeal Neoplasms | 2 | 2016 | 1241 | 0.090 |
Why?
|
Computers | 1 | 2012 | 612 | 0.090 |
Why?
|
Software Validation | 1 | 2009 | 59 | 0.090 |
Why?
|
Liver | 3 | 2022 | 7475 | 0.090 |
Why?
|
Blood Vessels | 1 | 2015 | 1125 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2219 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35425 | 0.090 |
Why?
|
Risk | 3 | 2018 | 9688 | 0.080 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2008 | 40 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8664 | 0.080 |
Why?
|
Dental Implants | 1 | 2017 | 750 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1276 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1149 | 0.080 |
Why?
|
Benchmarking | 2 | 2015 | 1042 | 0.080 |
Why?
|
X-Rays | 2 | 2017 | 301 | 0.080 |
Why?
|
Body Burden | 1 | 2008 | 158 | 0.080 |
Why?
|
Sphenoid Sinus | 1 | 2008 | 99 | 0.080 |
Why?
|
Whole Body Imaging | 1 | 2010 | 280 | 0.080 |
Why?
|
Neuroectodermal Tumors | 1 | 2007 | 27 | 0.080 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
Spinal Cord | 1 | 2015 | 1810 | 0.070 |
Why?
|
Nuclear Warfare | 1 | 2007 | 31 | 0.070 |
Why?
|
Thorax | 1 | 2010 | 547 | 0.070 |
Why?
|
Mutation | 4 | 2019 | 29786 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 1771 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1071 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2020 | 1813 | 0.070 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 271 | 0.070 |
Why?
|
Haplorhini | 1 | 2007 | 552 | 0.070 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1462 | 0.070 |
Why?
|
Aged | 6 | 2020 | 163288 | 0.070 |
Why?
|
Spinal Cord Neoplasms | 1 | 2008 | 281 | 0.070 |
Why?
|
Magnetics | 1 | 2008 | 606 | 0.060 |
Why?
|
Mice | 8 | 2016 | 81201 | 0.060 |
Why?
|
Rad51 Recombinase | 2 | 2016 | 189 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9240 | 0.060 |
Why?
|
Risk Factors | 4 | 2022 | 72296 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2716 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7282 | 0.060 |
Why?
|
Pituitary Neoplasms | 2 | 2016 | 1345 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5534 | 0.060 |
Why?
|
Primates | 1 | 2007 | 545 | 0.060 |
Why?
|
Lethal Dose 50 | 1 | 2003 | 77 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2007 | 3326 | 0.060 |
Why?
|
Boron Neutron Capture Therapy | 1 | 2003 | 51 | 0.060 |
Why?
|
Astrocytoma | 1 | 2008 | 790 | 0.060 |
Why?
|
Mitochondria | 1 | 2016 | 3514 | 0.060 |
Why?
|
Fanconi Anemia | 2 | 2016 | 319 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 1 | 2002 | 118 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3841 | 0.050 |
Why?
|
Incidence | 4 | 2018 | 20952 | 0.050 |
Why?
|
Helium | 1 | 2022 | 123 | 0.050 |
Why?
|
Middle Aged | 8 | 2020 | 213390 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11031 | 0.050 |
Why?
|
Dogs | 1 | 2007 | 3912 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 8987 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4216 | 0.050 |
Why?
|
Palliative Care | 1 | 2016 | 3493 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3749 | 0.050 |
Why?
|
Swine | 1 | 2011 | 5918 | 0.050 |
Why?
|
Body Weight | 1 | 2012 | 4671 | 0.050 |
Why?
|
Leukemia P388 | 1 | 2000 | 16 | 0.050 |
Why?
|
Clinical Competence | 1 | 2016 | 4687 | 0.050 |
Why?
|
Fibroblasts | 2 | 2020 | 4162 | 0.050 |
Why?
|
Macaca mulatta | 1 | 2007 | 2377 | 0.050 |
Why?
|
Visible Human Projects | 1 | 2019 | 7 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2021 | 323 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.040 |
Why?
|
Bone Marrow | 1 | 2010 | 2948 | 0.040 |
Why?
|
Laboratories | 1 | 2003 | 463 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4925 | 0.040 |
Why?
|
Actuarial Analysis | 1 | 2019 | 378 | 0.040 |
Why?
|
Blood Cells | 1 | 2021 | 309 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2000 | 327 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10637 | 0.040 |
Why?
|
Cataract Extraction | 1 | 2003 | 481 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 29060 | 0.040 |
Why?
|
Microspheres | 1 | 2021 | 777 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 629 | 0.040 |
Why?
|
Biophysics | 1 | 2000 | 383 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9724 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9647 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.040 |
Why?
|
Chemical Phenomena | 1 | 2018 | 518 | 0.040 |
Why?
|
Young Adult | 7 | 2019 | 56429 | 0.040 |
Why?
|
Texas | 1 | 2018 | 391 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 457 | 0.040 |
Why?
|
Florida | 1 | 2018 | 435 | 0.040 |
Why?
|
United States | 4 | 2018 | 69872 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2943 | 0.040 |
Why?
|
Cesium Radioisotopes | 1 | 2016 | 36 | 0.030 |
Why?
|
Vinblastine | 1 | 2017 | 502 | 0.030 |
Why?
|
Stochastic Processes | 1 | 2017 | 344 | 0.030 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 212 | 0.030 |
Why?
|
Carboplatin | 1 | 2018 | 801 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 402 | 0.030 |
Why?
|
Growth Plate | 1 | 2017 | 274 | 0.030 |
Why?
|
Biochemical Phenomena | 1 | 2015 | 59 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2008 | 2282 | 0.030 |
Why?
|
Teratoma | 1 | 2017 | 395 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 2016 | 165 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2016 | 743 | 0.030 |
Why?
|
Penis | 1 | 2016 | 217 | 0.030 |
Why?
|
Self-Assessment | 1 | 2016 | 390 | 0.030 |
Why?
|
Sex Factors | 1 | 2008 | 10400 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5511 | 0.030 |
Why?
|
Rats | 1 | 2010 | 24252 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.030 |
Why?
|
Survival Rate | 1 | 2008 | 12788 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39052 | 0.030 |
Why?
|
Thigh | 1 | 2015 | 247 | 0.030 |
Why?
|
Phthalazines | 1 | 2016 | 363 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 913 | 0.030 |
Why?
|
Permeability | 1 | 2015 | 738 | 0.030 |
Why?
|
Neuroma, Acoustic | 1 | 2016 | 451 | 0.030 |
Why?
|
Rotation | 1 | 2014 | 523 | 0.030 |
Why?
|
Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2019 | 1431 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2017 | 2971 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2012 | 25628 | 0.030 |
Why?
|
Plasmids | 1 | 2016 | 2308 | 0.020 |
Why?
|
Cisplatin | 1 | 2017 | 1662 | 0.020 |
Why?
|
Particle Size | 1 | 2015 | 1642 | 0.020 |
Why?
|
Thermal Conductivity | 1 | 2010 | 16 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 840 | 0.020 |
Why?
|
Esophagus | 1 | 2017 | 1019 | 0.020 |
Why?
|
Fast Neutrons | 1 | 2010 | 18 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1240 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2307 | 0.020 |
Why?
|
Thyroid Gland | 1 | 2017 | 1173 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4372 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 976 | 0.020 |
Why?
|
Air | 1 | 2009 | 182 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2011 | 252 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2598 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2010 | 292 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2949 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4894 | 0.020 |
Why?
|
Sacrum | 1 | 2010 | 288 | 0.020 |
Why?
|
Cerebellum | 1 | 2015 | 1488 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2618 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5451 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2700 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4446 | 0.020 |
Why?
|
Adenoma | 1 | 2016 | 2174 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5895 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
Cell Communication | 1 | 2012 | 1621 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3759 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8662 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10483 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.020 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.020 |
Why?
|
Glioblastoma | 1 | 2019 | 3481 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13286 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3582 | 0.010 |
Why?
|
Bone and Bones | 1 | 2014 | 2576 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7184 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 63107 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11525 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53290 | 0.010 |
Why?
|